All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
LevFinLevFin High Yield Bonds

Grifols formulates first euros in final refi deal

Pharmaceutical 230x150

Potential high yield bond issuance for this week shot up above €2.4bn with a new €1bn offering from Grifols, the plasma medicine manufacturer based in Barcelona, which is closing the last leg of its debt refinancing.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree